AD |
Alzheimer’s Disease |
ADMA |
asymmetric dimethylarginine |
AT1 |
angiotensin II type 1 receptor |
Aβ |
amyloid beta |
β-amyloid1–40
|
beta-amyloid1–40
|
BBB |
blood–brain barrier |
Ca2+
|
calcium |
CADASIL |
cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy |
Cav-1 |
caveolin-1 |
CD40 |
CD40 ligand |
CDR |
Clinical Dementia Rating Scale |
CRP |
C-reactive protein |
CSF |
cerebrospinal fluid |
CT |
computerised tomography |
CVR |
cerebrovascular reactivity |
DCE-MRI |
dynamic contrast-enhanced MRI |
DTI |
diffusion tensor imaging |
EDE |
endothelial-derived exosome |
eNOS |
endothelial nitric oxide synthase |
E-selectin |
endothelial selectin |
ET-1 |
endothelin-1 |
GLUT-1 |
glucose transporter-1 |
Hcy |
homocysteine |
HbA1c |
haemoglobin A1c |
ICAM-1 |
intracellular cell adhesion molecule-1 |
ICV |
intracranial volume |
IL-6 |
interleukin-6 |
K+
|
potassium |
LAT-1 |
large neutral amino acid transporter-1 |
Lp-PLA2
|
lipoprotein-associated phospholipase A2-mass |
MCI |
mild cognitive impairment |
MRI |
magnetic resonance imaging |
NO |
nitric oxide |
NOS |
nitric oxide synthase |
NOSTRIN |
endothelial nitric oxide synthase traffic inducer |
PAI-1 |
plasminogen activator inhibitor-1 |
PF-4 |
platelet factor-4 |
P-GP |
permeability-glycoprotein |
PlGF |
placental growth factor |
P-selectin |
platelet selectin |
PVS |
perivascular spaces |
ROS |
reactive oxygen species |
sVCAM-1 |
soluble vascular cell adhesion molecule-1 |
SVD |
small vessel disease |
TF |
tissue factor |
TFPI |
tissue factor pathway inhibitor |
TGF-β1 |
transforming growth factor- β 1 |
TM |
thrombomodulin |
TNFR1 |
tumour necrosis factor receptor 1 |
TNFR2 |
tumour necrosis factor receptor 2 |
TNF-α |
tumour necrosis factor alpha |
t-PA |
tissue-type plasminogen activator |
VCAM-1 |
vascular cell adhesion molecule-1 |
VEGF |
vascular endothelial growth factor |
vWF |
von Willebrand Factor |
WMH |
white matter hyperintensities |